COMPANY PROFILE

Evvy

Explore full profile

AI-powered vaginal microbiome diagnostics and precision women’s care

New York City, United StatesFounded 2020Health Tech & Medtech

Valuation $100–250M Last recorded · 2026

Headcount <100 Current team size

Total funding $50–100M Disclosed equity funding

Unlock exact values

About Evvy

Evvy is a New York women’s health company offering an at-home CLIA- and CLEP-certified metagenomic next-generation sequencing (mNGS) vaginal microbiome test with clinician review, personalized care pathways and an AI advisor (EvvyAI) that turns molecular results into actionable guidance. Founded in 2021 by CEO Priyanka Jain with Laine Bruzek and Pita Navarro, Evvy says it has served more than 100,000 patients, works with about 3,000 practitioners, published peer-reviewed research identifying BV subtypes and previously uncatalogued genomes, and is expanding into fertility and reproductive outcomes including IVF clinic studies. The company aims to close the gender health data gap by linking microbiome biology, symptoms, treatments and outcomes for precision medicine. In September 2026 Evvy raised a $40 million Series B led by Catalio Capital Management, bringing total equity funding to about $60 million to scale diagnostics, care and research. Sources: TechCrunch 15 Sep 2026; Fortune / AlleyWatch Sep 2026.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2020
Headquarters: New York City, United States
Employees: 62
Open positions: 4
Dealroom signal: 77.8/100
Industry: Health
Sub-industry: Medical Devices
Sector: Health Tech & Medtech, Fertility, Biotechnology, Women's Health, Health Diagnostics, Microbiome, Femtech, Digital Therapeutics, Hard Tech, Woman Founder
Technology: Deep Tech
Business model: Manufacturing
Client focus: b2c
Links: Website LinkedIn X

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

2 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES A✓Equity / VC	Sep 2023	$14M	$56M	General Catalyst · Human Ventures · Left Lane Capital · Ingeborg Investments	↗
SEED✓Equity / VC	Jul 2021	$5M	$20M	BoxGroup · Human Ventures · G9 Ventures · BBG Ventures	—

Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Evvy website traffic

Latest recorded traffic for Evvy is 330K monthly website visits, down 45.9% over the last three months. Evvy's team grew 3.3% over the past year.

Latest monthly visits330K 3-month web change-45.9% 1-year team growth+3.3%

Monthly website visitsJan 2022–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Open positions

Openings linked to this company in Dealroom

Fertility Account DirectorNew York, New York, United States, Northern America, Americas · Sales · Jul 23, 2026 Clinical Success & Operations ManagerNew York, New York, United States, Northern America, Americas · Other · Jul 23, 2026 Translational ML ScientistNew York, New York, United States, Northern America, Americas · Other · Jul 23, 2026 Study ManagerNew York, New York, United States, Northern America, Americas · Project Management · Jul 23, 2026

4 distinct openings shownExplore hiring signals →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
MIMicrogenesisCreating the most advanced technologies in the world to help to restore the maximum potential of fertility	Detroit, United States	Operational	9	—	—
VGVivoSensMedical GmbHCombines medical-scientific experience	Leipzig, Germany	Operational
IVIvaryEnables women freedom in family and life planning with the Ovarian Reserve Test	Vienna, Austria	Acquired
BFBéa FertilityFirst at-home, clinical-standard fertility treatment, increasing access to effective and affordable treatments	London, United Kingdom	Operational
INInneBiotech startup building a hormone-based mini lab for women	Berlin, Germany	Operational
SHSyrona HealthDigital therapeutics for Endometriosis and Gynaecological Health	London, United Kingdom	Operational
DNDnaNudgeDNA-based guidance for personalized shopping and health choices	London, United Kingdom	Operational
AVAveta.LifePaving the way towards personalized women’s health	Weehawken, United States	Operational